Pilot Study of Minocycline in Huntington's Disease
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to assess the impact of minocycline on the progression of
symptoms of HD. The study will also assess whether it is reasonable to continue with further
study of minocycline in HD. We will measure the effect of minocycline on HD by measuring the
change in Huntington's disease symptoms.